about
Androgen deprivation therapy for prostate cancer-review of indications in 2010Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risksImmediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up studySystemic therapy for the treatment of hormone-sensitive metastatic prostate cancer: from intermittent androgen deprivation therapy to chemotherapy.Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer.Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Timing and choice of androgen ablation.
@ast
Timing and choice of androgen ablation.
@en
type
label
Timing and choice of androgen ablation.
@ast
Timing and choice of androgen ablation.
@en
prefLabel
Timing and choice of androgen ablation.
@ast
Timing and choice of androgen ablation.
@en
P2860
P356
P1476
Timing and choice of androgen ablation.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.PCAN.4500733
P577
2004-01-01T00:00:00Z